Newsfeeds - Spark Newswire

1 minute read

Four-Year Biktarvy Data Show High Efficacy, Durable Viral Suppression In Untreated HIV Patients

Today, 3:14 PM

Gilead Sciences Inc (NASDAQ:GILD) announced long-term Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) data showing high…

GILD

1 minute read

Gilead’s Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients

By Vandana Singh

Today, 3:14 PM

Gilead Sciences Inc (NASDAQ:GILD) announced new Phase 3 data from the ongoing CAPELLA trial evaluating lenacapavir, its investigational, long-acting HIV-1 capsid…

GILD

2 minute read

Analyzing Gilead Sciences’s Unusual Options Activity

By Benzinga Insights

Today, 3:14 PM

Gilead Sciences (NASDAQ:GILD) shares experienced unusual options activity on Friday. The stock price moved up to $68.72 following the option alert.

GILD

3 minute read

Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?

By Shanthi Rexaline

Today, 3:14 PM

Moderna Inc (NASDAQ: MRNA) stock is on a roll, with its vaccine-induced momentum spilling over into 2021.

BNTX

4 minute read

Gilead To Present Abstracts At IAS 2021

By Bill Haddad

Today, 3:14 PM

Gilead Sciences, Inc. (NASDAQ:GILD) today announced the company's upcoming contributions to the 11th International AIDS Society (IAS) Conference on HIV Science, taking place virtually from July 18-21. Thirty-one

GILD

2 minute read

Understanding Gilead Sciences’s Unusual Options Activity

By Benzinga Insights

Today, 3:14 PM

Gilead Sciences (NASDAQ:GILD) shares experienced unusual options activity on Thursday. The stock price moved down to $67.64 following the option alert.

GILD

2 minute read

Analyzing Gilead Sciences’s Unusual Options Activity

By Benzinga Insights

Today, 3:14 PM

Shares of Gilead Sciences (NASDAQ:GILD) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $69.27.

GILD

3 minute read

Donald Rumsfeld, Two-Time Defense Secretary, Dies At 88

By Phil Hall

Today, 3:14 PM

Donald Rumsfeld, who served as Secretary of Defense when President George W. Bush sent U.S. military forces into Afghanistan in pursuit of al-Qaeda and into Iraq to topple the Saddam Hussein regime, has died at the age of 88 in Taos, New Mexico.

GILD

1 minute read

Gilead, Foresite Take Pardes Biosciences Public In $250M SPAC Deal

By Vandana Singh

Today, 3:14 PM

Pardes Biosciences Inc, an early-stage biopharmaceutical company, and FS Development Corp. II (NASDAQ:FSII), a Foresite Capital sponsored SPAC, entered into a…

FSII

5 minute read

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

By Shanthi Rexaline

Today, 3:14 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)

ABUS